COGT peer analysis
Cogent Biosciences (COGT) against its competitors: price, today's move, 1-year return and market value side by side.
COGT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AVBP ArriVent BioPharma | $13.52 | 10.58% | -25.53% | – |
| IDYA IDEAYA Biosciences | $31.24 | 1.92% | 5.36% | $2.75B |
| INCY Incyte | $120.00 | 1.69% | 13.10% | $24.37B |
| KURA Kura Oncology | $7.27 | 6.91% | -26.86% | $646.74M |
| MAZE Maze Therapeutics | $34.69 | 6.64% | 13.05% | – |
| NRIX Nurix Therapeutics | $15.07 | 1.55% | 23.48% | – |
| RCUS Arcus Biosciences | $18.28 | 3.34% | -7.49% | $2.33B |
| SNDX Syndax Pharmaceuticals | $9.70 | 3.52% | -35.17% | $867.49M |
| TNGX Tango Therapeutics | $21.50 | 3.02% | 186.09% | – |
| COGT Cogent Biosciences | $31.55 | 6.66% | 119.35% | – |
- COGT's peers: AVBP (ArriVent BioPharma), IDYA (IDEAYA Biosciences), INCY (Incyte), KURA (Kura Oncology), MAZE (Maze Therapeutics), NRIX (Nurix Therapeutics), RCUS (Arcus Biosciences), SNDX (Syndax Pharmaceuticals).
Updated 2026-11-07 11:54 UTC